Assessing the Comparative Effect of Tocilizumab on Risk of Cardiovascular Disease among Rheumatoid Arthritis Patients Using Claims Data: A Direct Comparison among Biologic Disease-Modifying Antirheumatic Drugs - ProQuest

Skip to main content

This graduate work has been published as open access.

Copyright information

Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.

View related documents

Your library or institution may also provide you access to related full text documents in ProQuest.

Explore ProQuest

Assessing the Comparative Effect of Tocilizumab on Risk of Cardiovascular Disease among Rheumatoid Arthritis Patients Using Claims Data: A Direct Comparison among Biologic Disease-Modifying Antirheumatic Drugs

Xie, Fenglong. The University of Alabama at Birmingham ProQuest Dissertations & Theses, 2018. 10750692.